Rapid digital detection of infections and treatment optimization
For decades, lab technicians have detected infections through crude, time-consuming, error-ridden techniques of dipsticks and specimen sampling, leaving physicians to guess which antibiotic might be effective since reliable results take days to develop. Avails Medical has developed digital technology to provide accurate, reproducible, rapid detection of infections in any bodily fluid while indicating real-time which drugs are most effective at the point-of-prescription. Avails' electronic biosensor technology improves accuracy in detecting infections and provides critical, timely information regarding antibiotic sensitivity and resistance. Avails' cost-effective platform will transform the diagnostics market by enabling diagnostic-guided therapy at the point-of-care for the first time, reducing time-to-treatment from days to minutes.